Advertisement
Screener

GLOBUS MEDICAL, INC. (GMED) Business Combination, Acquisition Related Costs

2.9 / 5 stars · 70/120 Roast Me

GLOBUS MEDICAL, INC. Business Combination, Acquisition Related Costs

GLOBUS MEDICAL, INC. (GMED) reported Business Combination, Acquisition Related Costs of $11.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:BusinessCombinationAcquisitionRelatedCosts · last filed 2026-08-06

  • GLOBUS MEDICAL, INC. business combination, acquisition related costs for the quarter ending 2026-06-30 was $11.08M, a 66.58% decline year-over-year.
  • GLOBUS MEDICAL, INC. business combination, acquisition related costs for the quarter ending 2026-03-31 was $6.38M, a 503.31% increase year-over-year.
  • GLOBUS MEDICAL, INC. business combination, acquisition related costs for the quarter ending 2025-12-31 was $10.83M, a 36.65% decline year-over-year.
  • GLOBUS MEDICAL, INC. business combination, acquisition related costs for the quarter ending 2025-09-30 was -$2.71M.
  • GLOBUS MEDICAL, INC. business combination, acquisition related costs for fiscal 2025 was $42.33M, a 42.88% increase from fiscal 2024.
  • GLOBUS MEDICAL, INC. business combination, acquisition related costs for fiscal 2024 was $29.62M, a 56.61% decline from fiscal 2023.
  • GLOBUS MEDICAL, INC. business combination, acquisition related costs for fiscal 2023 was $68.27M, a 1045.73% increase from fiscal 2022.
  • GLOBUS MEDICAL, INC. business combination, acquisition related costs for fiscal 2022 was $5.96M, a 64.91% decline from fiscal 2021.
Period endBusiness Combination, Acquisition Related Costs 3 monthBusiness Combination, Acquisition Related Costs 6 monthBusiness Combination, Acquisition Related Costs 9 monthBusiness Combination, Acquisition Related Costs 9 month as first filedBusiness Combination, Acquisition Related Costs 12 month
2026-06-30$11.08M
10-Q · filed 2026-08-06
$17.46M
10-Q · filed 2026-08-06
$28.28M
derived: sum of 3 quarters · filed 2026-08-06
$25.57M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$6.38M
10-Q · filed 2026-05-07
$17.20M
derived: sum of 2 quarters · filed 2026-05-07
$14.49M
derived: sum of 3 quarters · filed 2026-05-07
$47.65M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$10.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$8.11M
derived: sum of 2 quarters · filed 2026-02-24
$41.27M
derived: sum of 3 quarters · filed 2026-08-06
$42.33M
10-K · filed 2026-02-24
2025-09-30-$2.71M
10-Q · filed 2025-11-06
$30.44M
derived: sum of 2 quarters · filed 2026-08-06
$31.50M
10-Q · filed 2025-11-06
$48.59M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$33.16M
10-Q · filed 2026-08-06
$34.21M
10-Q · filed 2026-08-06
$51.30M
derived: sum of 3 quarters · filed 2026-08-06
$47.68M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.06M
10-Q · filed 2026-05-07
$18.14M
derived: sum of 2 quarters · filed 2026-05-07
$14.53M
derived: sum of 3 quarters · filed 2026-05-07
$28.26M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$17.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$13.47M
derived: sum of 2 quarters · filed 2026-02-24
$27.20M
derived: sum of 3 quarters · filed 2026-02-24
$29.62M
10-K · filed 2026-02-24
2024-09-30-$3.62M
10-Q · filed 2025-11-06
$10.12M
derived: sum of 2 quarters · filed 2025-11-06
$12.54M
10-Q · filed 2025-11-06
$28.12M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30$13.73M
10-Q · filed 2025-08-07
$16.15M
10-Q · filed 2025-08-07
$31.73M
derived: sum of 3 quarters · filed 2026-02-24
$77.36M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31$2.42M
10-Q · filed 2025-05-08
$18.00M
derived: sum of 2 quarters · filed 2026-02-24
$63.62M
derived: sum of 3 quarters · filed 2026-02-24
$69.33M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$15.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$61.21M
derived: sum of 2 quarters · filed 2026-02-24
$66.91M
derived: sum of 3 quarters · filed 2026-02-24
$68.27M
10-K · filed 2026-02-24
2023-09-30$45.63M
10-Q · filed 2024-11-05
$51.33M
derived: sum of 2 quarters · filed 2024-11-05
$52.69M
10-Q · filed 2024-11-05
$60.48M
derived: sum of 4 quarters · filed 2025-02-20
2023-06-30$5.71M
10-Q · filed 2024-08-06
$7.07M
10-Q · filed 2024-08-06
$14.86M
derived: sum of 3 quarters · filed 2025-02-20
$14.21M
derived: sum of 4 quarters · filed 2025-02-20
2023-03-31$1.36M
10-Q · filed 2024-05-07
$9.15M
derived: sum of 2 quarters · filed 2025-02-20
$8.50M
derived: sum of 3 quarters · filed 2025-02-20
$7.40M
derived: sum of 4 quarters · filed 2025-02-20
2022-12-31$7.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
$7.14M
derived: sum of 2 quarters · filed 2025-02-20
$6.04M
derived: sum of 3 quarters · filed 2025-02-20
$5.96M
10-K · filed 2025-02-20
2022-09-30-$652.00K
10-Q · filed 2023-11-07
-$1.76M
derived: sum of 2 quarters · filed 2023-11-07
-$1.83M
10-Q · filed 2023-11-07
$645.00K
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30-$1.10M
10-Q · filed 2023-08-03
-$1.18M
10-Q · filed 2023-08-03
$1.30M
derived: sum of 3 quarters · filed 2024-02-21
$1.66M
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31-$76.00K
10-Q · filed 2023-05-04
$2.40M
derived: sum of 2 quarters · filed 2024-02-21
$2.76M
derived: sum of 3 quarters · filed 2024-02-21
$16.63M
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31$2.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
$2.84M
derived: sum of 2 quarters · filed 2024-02-21
$16.71M
derived: sum of 3 quarters · filed 2024-02-21
$16.98M
10-K · filed 2024-02-21
2021-09-30$363.00K
10-Q · filed 2022-11-08
$14.23M
derived: sum of 2 quarters · filed 2022-11-08
$14.51M
10-Q · filed 2022-11-08
$16.67M
derived: sum of 4 quarters · filed 2023-02-21
2021-06-30$13.87M
10-Q · filed 2022-08-04
$14.14M
10-Q · filed 2022-08-04
$16.31M
derived: sum of 3 quarters · filed 2023-02-21
$17.57M
derived: sum of 4 quarters · filed 2023-02-21
2021-03-31$274.00K
10-Q · filed 2022-05-10
$2.44M
derived: sum of 2 quarters · filed 2023-02-21
$3.70M
derived: sum of 3 quarters · filed 2023-02-21
$3.76M
derived: sum of 4 quarters · filed 2023-02-21
2020-12-31$2.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21
$3.43M
derived: sum of 2 quarters · filed 2023-02-21
$3.48M
derived: sum of 3 quarters · filed 2023-02-21
$4.03M
10-K · filed 2023-02-21
2020-09-30$1.26M
10-Q · filed 2021-11-04
$1.32M
derived: sum of 2 quarters · filed 2021-11-04
$1.87M
10-Q · filed 2021-11-04
$3.20M
derived: sum of 4 quarters · filed 2022-02-17
2020-06-30$56.00K
10-Q · filed 2021-08-04
$604.00K
10-Q · filed 2021-08-04
$1.93M
derived: sum of 3 quarters · filed 2022-02-17
$2.49M
derived: sum of 4 quarters · filed 2022-02-17
2020-03-31$548.00K
10-Q · filed 2021-05-04
$1.88M
derived: sum of 2 quarters · filed 2022-02-17
$2.44M
derived: sum of 3 quarters · filed 2022-02-17
$2.54M
derived: sum of 4 quarters · filed 2022-02-17
2019-12-31$1.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
$1.89M
derived: sum of 2 quarters · filed 2022-02-17
$2.00M
derived: sum of 3 quarters · filed 2022-02-17
$2.58M
10-K · filed 2022-02-17
2019-09-30$559.00K
10-Q · filed 2020-10-28
$665.00K
derived: sum of 2 quarters · filed 2020-10-28
$1.25M
10-Q · filed 2020-10-28
$1.24M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-30$106.00K
10-Q · filed 2020-08-05
$685.00K
10-Q · filed 2020-08-05
$685.00K
derived: sum of 3 quarters · filed 2021-02-17
$953.00K
derived: sum of 4 quarters · filed 2021-02-17
2019-03-31$579.00K
10-Q · filed 2020-05-07
$579.00K
derived: sum of 2 quarters · filed 2021-02-17
$847.00K
derived: sum of 3 quarters · filed 2021-02-17
$1.63M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-31$0.00
derived: 10-K 12 month − 10-K 9 month · filed 2021-02-17
$268.00K
derived: sum of 2 quarters · filed 2021-02-17
$1.05M
derived: sum of 3 quarters · filed 2021-02-17
$1.68M
10-K · filed 2021-02-17
2018-09-30$268.00K
10-Q · filed 2019-11-06
$1.05M
derived: sum of 2 quarters · filed 2019-11-06
$1.68M
10-K · filed 2020-02-20
$1.29M
10-Q · filed 2018-11-08
$1.61M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$782.00K
10-Q · filed 2019-08-01
$1.02M
10-Q · filed 2019-08-01
$1.34M
derived: sum of 3 quarters · filed 2020-03-02
$1.63M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$238.00K
10-Q · filed 2019-05-02
$559.00K
derived: sum of 2 quarters · filed 2020-03-02
$844.00K
derived: sum of 3 quarters · filed 2020-03-02
$1.46M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$321.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02
$606.00K
derived: sum of 2 quarters · filed 2020-03-02
$1.22M
derived: sum of 3 quarters · filed 2020-03-02
$1.61M
10-K/A · filed 2020-03-02
2017-09-30$285.00K
10-Q · filed 2018-11-08
$902.00K
derived: sum of 2 quarters · filed 2018-11-08
$1.29M
10-Q · filed 2018-11-08
$1.77M
derived: sum of 4 quarters · filed 2019-02-21
2017-06-30$617.00K
10-Q · filed 2018-08-02
$1.00M
10-Q · filed 2018-08-02
$1.48M
derived: sum of 3 quarters · filed 2019-02-21
$2.68M
derived: sum of 4 quarters · filed 2019-02-21
2017-03-31$388.00K
10-Q · filed 2018-05-03
$867.00K
derived: sum of 2 quarters · filed 2019-02-21
$2.06M
derived: sum of 3 quarters · filed 2019-02-21
$1.54M
derived: sum of 4 quarters · filed 2019-02-21
2016-12-31$479.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21
$1.67M
derived: sum of 2 quarters · filed 2019-02-21
$1.15M
derived: sum of 3 quarters · filed 2019-02-21
$1.83M
10-K · filed 2019-02-21
2016-09-30$1.19M
10-Q · filed 2017-11-09
$673.00K
derived: sum of 2 quarters · filed 2017-11-09
$1.35M
10-Q · filed 2017-11-09
2016-06-30-$519.00K
10-Q · filed 2017-08-03
$155.00K
10-Q · filed 2017-08-03
2015-12-31$3.35M
10-K · filed 2018-02-22
2014-12-31-$937.00K
10-K · filed 2017-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
Penumbra Inc (PEN)United States$12.596B77.33
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
Solventum Corp (SOLV)United States$15.085B9.16
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B